Michelle Breckenridge
Papers
1
Total Citations
49
H-Index
1
About
Michelle Breckenridge is a leading urological researcher whose work centers on improving the diagnostic accuracy and clinical management of prostate cancer. Her primary research areas include optimizing prostate biopsy techniques and refining risk stratification for patients. Breckenridge’s most impactful contribution is her landmark comparative analysis of transperineal template biopsy (TTB) versus the standard transrectal ultrasound-guided biopsy (TRUSB). This study, cited 49 times, demonstrated that TTB significantly reduces the well-known phenomenon of Gleason score upgrading after radical prostatectomy, thereby providing a more accurate assessment of clinical risk category. Her findings have directly influenced clinical guidelines, advocating for the adoption of transperineal approaches to minimize diagnostic errors and better tailor treatment decisions. By highlighting the limitations of traditional biopsy methods, Breckenridge has advanced the precision of prostate cancer diagnosis, ultimately improving patient outcomes. Her work remains a cornerstone reference for researchers and clinicians seeking to enhance the reliability of prostate cancer staging and risk classification.
Research Focus
Key Achievements
Top Papers
- 1